Turkish Adaptation, Validity and Reliability of Cravings for Rest and Volitional Energy Expenditure (CRAVE)

September 8, 2022 updated by: Emel Mete, Istanbul Medeniyet University
The aim of this study is to adapt the Cravings for Rest and Volitional Energy Expenditure (CRAVE) scale to Turkish society and to make its validity and reliability in Turkish. The CRAVE scale developed by Stults-Kolehmainen et al assesses the intrinsic motivation required for sedentary behavior and participation in physical activity. It has 13 questions. CRAVE scale questions and questions in the data collection form will be prepared through the google surveys and will be sent to the participants via Whatsapp, Facebook, Instagram and e-mail. Participants will fill out the survey forms online. 130 participants will be included in the study. In order to evaluate the validity of the CRAVE, the Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2), which can measure exercise behaviors and intrinsic motivation and has been validated in Turkish, will be used. Scales will be repeated after 15 days to assess test-retest reliability.

Study Overview

Detailed Description

The reliability and validity of the scale will begin with language equivalence and cultural adaptation. The scale will be translated from English to Turkish by two people who are fluent in Turkish and English. A single Turkish translation will be obtained from these two Turkish translations with a common opinion. The scale, which has been translated into Turkish, will be translated into English by two other people who are fluent in Turkish and English. The scale translated into English will be compared with the original. If the developer of the scale, miguel blacutt and Stults-Kolehmainen approves the translation of the scale, participants will be recruited for the study. In the pre-trial phase, a pre-assessment will be conducted with 15 participants to test the intelligibility of the scale. Based on the results of the pre-test phase, the final version of CRAVE will be able to be modified. RAVE scale questions and questions in the data collection form will be prepared through the google surveys and will be sent to the participants via Whatsapp, Facebook, Instagram and e-mail. Participants will fill out the survey forms online. 130 participants will be included in the study. In order to evaluate the validity of the CRAVE, the Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2), which can measure exercise behaviors and intrinsic motivation and has been validated in Turkish, will be used. Scales will be repeated after 15 days to assess test-retest reliability.

Study Type

Observational

Enrollment (Anticipated)

130

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey, 34854
        • Recruiting
        • Emel Mete
      • Istanbul, Turkey, 34000
        • Recruiting
        • Emel Mete

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (ADULT)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

- Persons who meet the inclusion criteria and who volunteered to participate in the study.

Description

Inclusion Criteria:

  • Aged between 18-30 years
  • Adult individuals who have access to the Internet and agreed to participate in the study. -
  • Native language being Turkish

Exclusion Criteria:

  • Inability to use a computer, tablet or mobile phone
  • Native language not being Turkish

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
exercise motivation
Time Frame: baseline
Exercise motivation will be assessed with CRAVE scale. It consists of 13 items in total. Each item is scored on a scale of 0-10, ranging from "never" to "more than ever". The scale includes two sub-categories: "rest motivation" and "intrinsic motivation to move". There are 5 questions in the resting category and 5 questions in the moving category, and 3 questions are not scored. The score of each category is calculated by dividing the total score of the questions in that category by the number of questions.
baseline
exercise behaviour
Time Frame: baseline
Exercise behaviour will be assessed with BREQ-2 Scale. It comprises 19 items with ratings on a 5-point Likert scale ranging from 0 (not true for me) to 4 (very true for me). It measures amotivated (e.g., "I think exercising is a waste of time"), external (e.g., "I exercise because other people say I should"), introjected (e.g., "I feel guilty when I don't exercise"), identified (e.g., "it's important to me to exercise regularly"), and intrinsic (e.g., "I find exercise a pleasurable activity") regulations of exercise behavior.
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 5, 2022

Primary Completion (ACTUAL)

August 20, 2022

Study Completion (ANTICIPATED)

September 10, 2022

Study Registration Dates

First Submitted

February 10, 2022

First Submitted That Met QC Criteria

February 10, 2022

First Posted (ACTUAL)

February 21, 2022

Study Record Updates

Last Update Posted (ACTUAL)

September 9, 2022

Last Update Submitted That Met QC Criteria

September 8, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • CRAVE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise

Clinical Trials on Turkish Validity and Reliability of The CRAVE Scale

3
Subscribe